Clinical trial NCT00967083: Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
Official title: Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Lung Cancer
Keywords: Quality of Life
Questionnaires
Interviews
family members
care givers
09-104
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
Collaborators: name: Queens Cancer Center of Queens Hospital
name: Michigan State University
name: National Cancer Institute (NCI)
name: Indiana University
First posted: 2009-08-27
Enrollment: 53
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients whose family caregivers may be eligible for this study will be identified by a member of the patient's treatment team, the protocol investigator, or research team at Memorial Sloan-Kettering Cancer Center (MSKCC) or Queens Cancer Center (QCC).

Brief summary: This study is being done to learn what the needs are in relation to the family members. Some family members seek counseling; others do not. The institution wants to try to understand why and wants to see if they can improve our support services for family members.


Eligibility criteria: Inclusion Criteria:

* Primary family caregiver identified by a patient who is approximately within 4 to 6 weeks of a new visit to a thoracic clinic and receiving cancer care at Memorial Sloan-Kettering Cancer Center or Queens Cancer Center
* Caregiver is at least 18 years of age.
* Caregiver has adequate English fluency for completion of data collection. The surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.
* Clinically meaningful distress defined as a score of 8 or greater on the Anxiety or Depression subscale of the HADS (see Bjelland et al., 2002; Zigmond \& Snaith, 1983).

Exclusion Criteria:

* Patients or caregivers exhibiting significant psychiatric or cognitive impairment (dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation
* Patient has lung cancer recurrence
* Currently participating in a psychosocial intervention trial

Primary outcomes:
measure: Assess psychosocial info & practical needs of prim family caregivers of lung cancer pts.Mental health (anxiety & depression)& behavioral health needs(smoking cessation,alcohol abuse)will be assessed b/c these 2 types of needs are strongly correlate
timeFrame: 13 to 16 weeks
Secondary outcomes:
measure: To assess psychosocial and practical barriers to psychosocial support service use among primary family caregivers of lung cancer patients
timeFrame: 13 to 16 weeks
measure: To assess family caregivers' preferences (preferred topics, modality, provider, timing) regarding psychosocial support interventions.
timeFrame: 13 to 16 weeks
measure: To gather descriptive information regarding participant flow for planning future intervention studies.
timeFrame: 13 to 16 weeks
Other outcomes:
Locations:
city: Jamaica
country: United States
facility: Queens Cancer Center of Queens Hospital
state: New York
city: New York
country: United States
facility: Memorial Sloan Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: Jamie Ostroff, PhD
role: PRINCIPAL_INVESTIGATOR
References: